Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liquimat
- Development stage
- Unknown
- Lead developer
- Summers Laboratories
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Liquimat is an over-the-counter (OTC) topical acne treatment and medicated makeup developed by Summers Laboratories. Its primary active ingredient is 4% sulfur, which functions as a keratolytic agent to dry up existing pimples and help prevent the formation of new acne lesions. The product is formulated as a water-based, oil-free lotion that incorporates Color Matcher™ technology, allowing it to serve as a tint-adjustable foundation to mask skin imperfections while treating the condition. Liquimat is indicated for the management of acne and acne rosacea and is applied topically to the affected areas.
- Brand names
- Liquimat
Beyond the preview
Go deeper on Liquimat.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liquimat.